INDEPENDENT BIOMEDICAL DOSSIER • CLINICAL FORMULA & BIOAVAILABILITY ANALYSIS 2026
Tinnoril Clinical Monograph Seal
TINNORIL® Nutritional Research Monograph
Home / Safety, Purity & cGMP Standards

Safety, Purity & cGMP Standards

Learn about cGMP compliance, HPLC assay verification, ICP-MS heavy metal testing, and Certificate of Analysis standards for Tinnoril.

Quality Control, cGMP Compliance & Purity Standards

Tinnoril is manufactured strictly in compliance with United States Code of Federal Regulations (21 CFR Part 111) governing Current Good Manufacturing Practices (cGMP) for dietary supplements. Every phase of production is monitored by analytical quality assurance protocols.

1. FDA-Registered Facility & cGMP Certification

All blending, encapsulation, and packaging operations take place in an inspected laboratory facility located in the United States. Climate-controlled cleanrooms ensure that sensitive botanical extracts such as Coenzyme Q10 and Alpha Lipoic Acid are protected from heat, light, and humidity during processing.

2. Multi-Tier Heavy Metal & Contaminant Screening

Before encapsulation, raw botanical powders and minerals undergo inductively coupled plasma mass spectrometry (ICP-MS) testing to verify that heavy metal levels remain far below strict USP and Prop 65 safety limits:

3. Microbiological Assay & Pathogen Verification

Each batch is tested for total plate count, yeast and mold, Escherichia coli, Salmonella spp., and Staphylococcus aureus. Products are only released for distribution upon issuance of a formal Certificate of Analysis (CoA) confirming complete sterility and compliance.

4. Safety Profile & Suggested Usage Guidelines

Tinnoril is formulated for daily adult nutritional support. Adults take one (1) capsule daily with water. Individuals who are pregnant, nursing, under 18 years of age, taking prescription medications, or managing a medical condition should consult a licensed physician prior to initiating use.

ORDER FROM VERIFIED CGMP CERTIFIED PRODUCTION BATCH